Patients with moderate and severe disease developed higher levels of IgM and IgG antibodies to the receptor binding domain (RBD) of the spike protein of SARS-CoV-2 compared to patients suffering from mild disease or those with asymptomatic infections. The gene discussed is CD40LG; the disease is infection.